The presentation will outline the steps for achieving this goal.
This presentation will describe the manufacture and use of granulocyte concentrates derived from whole blood donations, outlining the advantages and drawbacks for the donors, healthcare professionals and the recipients.
This presentation will address their efficacy and mechanism of action.
This presentation will review the conservation treatment step by step.
This presentation will discuss the non-microstructural crack formation in detail and suggest a mechanism for the fatigue life degradation.
This presentation will illustrate examples from each of these projects.
During the presentation we will outline the basic concepts and architecture of the system and point out some key challenges that we were facing during its development.
This section will outline several approaches to self-knowledge.
This paper will outline the efficacy of this stress wave based monitoring methodology.
This paragraph will outline which steps were taken in order to perform this systematic review.
